{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:18:13Z","timestamp":1792610293653,"version":"4.5.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,22]],"date-time":"2016-11-22T00:00:00Z","timestamp":1479772800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12891-016-1335-x","type":"journal-article","created":{"date-parts":[[2016,11,22]],"date-time":"2016-11-22T12:46:45Z","timestamp":1479818805000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The efficacy of adalimumab in psoriatic arthritis concomitant to overlapping primary biliary cholangitis and primary sclerosing cholangitis: a case report"],"prefix":"10.1186","volume":"17","author":[{"given":"Teresa","family":"Del Ross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Ruffatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annarosa","family":"Floreani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariela","family":"Hoxha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Punzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,22]]},"reference":[{"key":"1335_CR1","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1055\/s-0034-1383734","volume":"34","author":"A Floreani","year":"2014","unstructured":"Floreani A, Franceschet I, Cagazzon N. Primary biliary cirrhosis: overlaps with other autoimmune disorders. Semin liver dis. 2014;34:352\u201360.","journal-title":"Semin liver dis"},{"key":"1335_CR2","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.autrev.2014.01.040","volume":"13","author":"KK Yimam","year":"2014","unstructured":"Yimam KK, Bowlus CL. Diagnosis and classification of primary sclerosing cholangitis. Autoimmun rev. 2014;13:445\u201350.","journal-title":"Autoimmun rev"},{"key":"1335_CR3","first-page":"236","volume":"26","author":"E D\u2019Amico","year":"1999","unstructured":"D\u2019Amico E, Palazzi C, Capani F. Remission of psoriatic arthritis after porto-caval anastomosis in a patient with primary biliary cirrhosis. J rheumatol. 1999;26:236.","journal-title":"J rheumatol"},{"key":"1335_CR4","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.dld.2015.02.002","volume":"47","author":"A Floreani","year":"2015","unstructured":"Floreani A, Motta R, Cagazzon N, Franceschet I, Roncalli M, Del Ross T, et al. The overlap syndrome between primary biliary cirrhosis and primary sclerosing cholangitis. Dig liver dis. 2015;47:432\u20135.","journal-title":"Dig liver dis"},{"key":"1335_CR5","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1136\/ard.2009.111856","volume":"69","author":"F Bosch Van den","year":"2010","unstructured":"Van den Bosch F, Manger B, Goupille P, Mchugh N, Rodevand E, Holk P, et al. Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions. Ann rheum dis. 2010;69:394\u20139.","journal-title":"Ann rheum dis"},{"key":"1335_CR6","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jaut.2009.09.010","volume":"33","author":"V Barak","year":"2009","unstructured":"Barak V, Selmi C, Schlesinger M, Blank M, Agmon-Levin N, Kalickman I, et al. Serum inflammatory cytokines, complement components, and soluble interleukin 2 receptor in primary biliary cirrhosis. J autoimm. 2009;33:178\u201382.","journal-title":"J autoimm"},{"key":"1335_CR7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.autrev.2004.09.003","volume":"4","author":"CA Aoki","year":"2005","unstructured":"Aoki CA, Bowlus CL, Gershwin ME. The immunobiology of primary sclerosing cholangitis. Autoimm rev. 2005;4:137\u201343.","journal-title":"Autoimm rev"},{"key":"1335_CR8","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/MCG.0b013e3181662426","volume":"42","author":"DW Hommes","year":"2008","unstructured":"Hommes DW, Erkelens W, Ponsioen C, Stokkers P, Rauws E, van der Spek M, et al. A double-blind placebo-controlled, randomized study of infliximab in primary sclerosing cholangitis. J clin gastroenterol. 2008;42:522\u20136.","journal-title":"J clin gastroenterol"},{"key":"1335_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jbspin.2007.03.003","volume":"75","author":"A Spadaro","year":"2008","unstructured":"Spadaro A, Scrivo R, Riccieri V, Valesini G. Effect of tumor necrosis factor alpha antagonists in a patient with rheumatoid arthritis and primary biliary cirrhosis. Joint bone spine. 2008;75:87\u20139.","journal-title":"Joint bone spine"},{"key":"1335_CR10","doi-asserted-by":"publisher","first-page":"590","DOI":"10.3748\/wjg.v19.i4.590","volume":"19","author":"I Duca","year":"2013","unstructured":"Duca I, Ram\u00edrez De La Piscina P, Estrada S, Calder\u00f2n R, Spicakova K, Urtasun L, et al. Steroid-refractory ulcerative colitis and associated primary sclerosing cholangitis treated with infliximab. World j gastroenterol. 2013;19:590\u20133.","journal-title":"World j gastroenterol"},{"key":"1335_CR11","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jbspin.2011.04.014","volume":"78","author":"S Kubo","year":"2011","unstructured":"Kubo S, Iwata S, Saito K, Tanaka Y. Successful treatment of primary biliary cirrhosis with etanercept in a patient with rheumatoid arthritis. Joint bone spine. 2011;78:535\u20136.","journal-title":"Joint bone spine"},{"key":"1335_CR12","first-page":"101","volume":"6","author":"JK Triantafillidis","year":"2013","unstructured":"Triantafillidis JK, Durakis S, Merikas E. Crohn\u2019s disease of the small bowel, complicated by primary biliary cirrhosis, Hashimoto thyroiditis, and Raynaud\u2019s phenomenon: favorable response of all disorders to adalimumab treatment. Gastroenterol hepatol bed bench. 2013;6:101\u20135.","journal-title":"Gastroenterol hepatol bed bench"},{"key":"1335_CR13","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/ng.2616","volume":"45","author":"JZ Liu","year":"2013","unstructured":"Liu JZ, Hov JR, Folseraas T, Ellinghaus E, Rushbrook SM, Doncheva NT, et al. Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. Nat genet. 2013;45:670\u20135.","journal-title":"Nat genet"},{"key":"1335_CR14","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s12041-013-0272-9","volume":"92","author":"S Lu","year":"2013","unstructured":"Lu S, Huang X, Zhong H, Chen Z, Peng Q, Deng Y, et al. Tumor necrosis factor alpha (TNF-alpha) genetic polymorphisms and the risk of autoimmune liver disease: a meta-analysis. J genet. 2013;92:617\u201328.","journal-title":"J genet"},{"key":"1335_CR15","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.jbspin.2012.02.003","volume":"79","author":"MJ Morales-Lara","year":"2012","unstructured":"Morales-Lara MJ, Canete JD, Torres-Moreno D, Hern\u00e1ndez MV, Pedrero F, Celis R, et al. Effects of polymorphisms in TRAILR1 and TNFR1A on the response to anti-TNF therapies in patients with rheumatoid and psoriatic arthritis. Joint bone spine. 2012;79:591\u20136.","journal-title":"Joint bone spine"},{"key":"1335_CR16","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1111\/jdv.13024","volume":"29","author":"C Simone De","year":"2015","unstructured":"De Simone C, Farina M, Maiorino A, Fanali C, Perino F, Flamin A, et al. TNF-alpha gene polymorphisms can help to predict response to etanercept in psoriatic patients. J eur acad dermatol venereol. 2015;29:1786\u201390.","journal-title":"J eur acad dermatol venereol"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-016-1335-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12891-016-1335-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-016-1335-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T22:09:43Z","timestamp":1487714983000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-016-1335-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,22]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1335"],"URL":"https:\/\/doi.org\/10.1186\/s12891-016-1335-x","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,22]]},"article-number":"485"}}